AMAdriana Morales-Martínez

Adriana Morales-Martínez

*This is an algorithmically generated author record based on publicly available information.

Adriana Morales-Martínez has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multirresistencia a antibióticos y alternativas para resolver esta crisis

    by Brandt Bertrand, Adriana Morales-Martínez, Pablo Luis Hernández-Adame, Carlos Muñoz-Garay

    Las evaluaciones estandarizadas en el ámbito educativo tienen una larga historia, que inicia a principios de siglo XX. El campo de la Psicología y de la Educación ha impactado enormemente el mundo educativo y, últimamente, ha servido para diseñar políticas públicas y para rendir cuentas a la sociedad. La principal característica de las pruebas estandarizadas es que pueden administrarse a una gran cantidad de personas, cuyas respuestas se califican de manera automática con dispositivos electrónicos. Su gran desventaja radica en que utilizan, principalmente, el formato de selección de respuestas que hace un tanto artificial la evaluación. A pesar de esta limitación, las evaluaciones estandarizadas se utilizan con una gran variedad de propósitos: desde la admisión a instituciones educativas hasta la evaluación de la calidad educativa de un país. A lo largo de su historia, las evaluaciones estandarizadas han sido objeto de críticas, algunas de ellas justas y otras no. Dada su importancia, el propósito de este texto es precisar lo que se entiende por evaluaciones estandarizadas de aprendizaje, describir su origen y evolución en el ámbito educativo, explicar sus principales usos y puntualizar las limitaciones y retos que tendrán.


  • Rich fatty acids diet of fish and olive oils modifies membrane properties in striatal rat synaptosomes

    by Adriana Morales-Martínez, Absalom Zamorano-Carrillo, Sergio Montes, Mohammed El-Hafidi, Alicia Sánchez-Mendoza, Elizabeth Soria-Castro, Juan Carlos Martínez-Lazcano, Pablo Eliasib Martínez-Gopar, Camilo Ríos, Francisca Pérez-Severiano

    Background: Essential fatty acids (EFAs) and non-essential fatty acids (nEFAs) exert experimental and clinical neuroprotection in neurodegenerative diseases. The main EFAs, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), nEFAs, and oleic acid (OA) contained in olive and fish oils are inserted into the cell membranes, but the exact mechanism through which they exert neuroprotection is still unknown. Objectives and Methods: In this study, we assessed the fatty acids content and membrane fluidity in striatal rat synaptosomes after fatty acid-rich diets (olive- or a fish-oil diet, 15% w/w). Then, we evaluated the effect of enriching striatum synaptosomes with fatty acids on the oxidative damage produced by the prooxidants ferrous sulfate (FeSO4) or quinolinic acid (QUIN). Results and Discussion: Lipid profile analysis in striatal synaptosomes showed that EPA content increased in the fish oil group in comparison with control and olive groups. Furthermore, we found that synaptosomes enriched with fatty acids and incubated with QUIN or FeSO4 showed a significant oxidative damage reduction. Results suggest that EFAs, particularly EPA, improve membrane fluidity and confer antioxidant effect.


  • Open Access

    Establishment and maintenance of an R6/1 transgenic mouse colony and validation of its progressive neurological phenotype to study Huntington’s disease

    by Lucía Gabriela García-Lara, Adriana Morales-Martínez, Quetzalli Denisse Angeles-López, Hilda Pedraza-Espitia, Iván Pérez-Neri, Cesar Augusto Rodríguez-Balderas, Francisca Pérez-Severiano

    Huntington’s disease (HD) is a hereditary neurodegenerative disorder of the central nervous system that mainly affects the basal ganglia and has no cure. The mutation is located at an abnormal expansion of the CAG triplet in the Huntingtin gene. Humans show psychiatric, behavioural and motor disorders. Transgenic animal models are essential to the study of HD since the disease only affects humans. Therefore, the aim of this article was to describe the formation and maintenance of and to validate the progressive neurological phenotype of an R6/1 transgenic mouse colony. To achieve our objective, the colony founder was imported from Jackson Laboratories, and the mice were kept under controlled environmental conditions. The animals were bred at the vivarium of the Instituto Nacional de Neurología y Neurocirugía Man­uel Velasco Suárez. The R6/1 transgenic mice were successfully bred and showed genetic and phenotypic characteristics similar to the ones previously reported. Our colony is currently established and validated with the condi­tions of our vivarium and has produced more than four generations of R6/1 mice. The establishment of the R6/1 colony and its maintenance through generation is an advantage since it allows us to follow the authenticity of the transgenic mice regarding their phenotypic and motor behaviours. Fur­thermore, these animals can be compared with other transgenic mice that reproduce some of the main characteristics of the disease manifested in hu­mans, making these transgenic R6/1 mice a useful tool for the study of HD.